{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:40:41Z","timestamp":1791387641555,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejrad.2021.109931","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T01:46:18Z","timestamp":1629683178000},"page":"109931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis"],"prefix":"10.1016","volume":"143","author":[{"given":"Zhifan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingru","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejrad.2021.109931_b0005","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1200\/JCO.2005.05.078","article-title":"Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group","volume":"23","author":"von Minckwitz","year":"2005","journal-title":"J. Clin. Oncol. Official J. Am. Society Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ejrad.2021.109931_b0010","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1200\/JCO.2005.02.6187","article-title":"Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update","volume":"24","author":"Kaufmann","year":"2006","journal-title":"J. Clin. Oncol. Official J. Am. Society Clin. Oncol."},{"key":"10.1016\/j.ejrad.2021.109931_b0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejrad.2017.06.019","article-title":"Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients","volume":"94","author":"Fan","year":"2017","journal-title":"Eur. J. Radiol."},{"issue":"8","key":"10.1016\/j.ejrad.2021.109931_b0020","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00330-004-2246-z","article-title":"Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy","volume":"14","author":"Londero","year":"2004","journal-title":"Eur. Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","article-title":"Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis","volume":"17","author":"Gu","year":"2017","journal-title":"Clinical Breast Cancer"},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1148\/radiol.12111177","article-title":"Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET\/CT and dynamic contrast-enhanced MR imaging\u2013prospective assessment","volume":"263","author":"Tateishi","year":"2012","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.ejrad.2021.109931_b0035","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1007\/s00330-016-4630-x","article-title":"Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations","volume":"27","author":"Bedair","year":"2017","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tranon.2015.11.016","article-title":"Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI","volume":"9","author":"Tudorica","year":"2016","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.ejrad.2021.109931_b0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.2007.14.7314","article-title":"Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm","volume":"26","author":"Morrow","year":"2008","journal-title":"J. Clin. Oncol. Official J. Am. Society Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ejrad.2021.109931_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiology.161.2.3763909","article-title":"MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders","volume":"161","author":"Le Bihan","year":"1986","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00330-011-2236-x","article-title":"Comparison of diffusion-weighted MR imaging and FDG PET\/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer","volume":"22","author":"Park","year":"2012","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2021.109931_b0060","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ (Clini. Res. Ed.)"},{"issue":"8","key":"10.1016\/j.ejrad.2021.109931_b0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ejrad.2021.109931_b0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/RCT.0000000000001001","article-title":"Comparison of Model-Free and Model-Based Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Parameters for Predicting Breast Cancers' Response to Neoadjuvant Chemotherapy","volume":"44","author":"Lv","year":"2020","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-018-1091-y","article-title":"Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)","volume":"21","author":"Gampenrieder","year":"2019","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0080","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3348\/kjr.2018.19.4.682","article-title":"Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer","volume":"19","author":"Kim","year":"2018","journal-title":"Korean J. Radiol."},{"issue":"1087","key":"10.1016\/j.ejrad.2021.109931_b0085","article-title":"Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy","volume":"91","author":"Henderson","year":"2018","journal-title":"Br. J. Radiol."},{"issue":"5","key":"10.1016\/j.ejrad.2021.109931_b0090","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.tranon.2017.07.005","article-title":"Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients","volume":"10","author":"You","year":"2017","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000475745","article-title":"Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Inflammatory Breast Cancer Prior to and After Neoadjuvant Treatment","volume":"12","author":"van Uden","year":"2017","journal-title":"Breast care (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-017-0899-1","article-title":"Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: A comparison with breast magnetic resonance imaging","volume":"19","author":"Iotti","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejrad.2021.109931_b0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40064-016-1800-x","article-title":"Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype","volume":"5","author":"Fukuda","year":"2016","journal-title":"SpringerPlus"},{"issue":"12","key":"10.1016\/j.ejrad.2021.109931_b0110","first-page":"958","article-title":"Comparative analysis between ultrasound and magnetic resonance imagining on assessment of neoadjuvant chemotherapy for breast cancer","volume":"22","author":"Dai","year":"2015","journal-title":"Chinese J. Cancer Prevention Treatment"},{"issue":"6","key":"10.1016\/j.ejrad.2021.109931_b0115","first-page":"785","article-title":"Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?","volume":"6","author":"Zhang","year":"2014","journal-title":"J. Thoracic Disease"},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1148\/radiol.14130569","article-title":"Changes in Primary Breast Cancer Heterogeneity May Augment Midtreatment MR Imaging Assessment of Response to Neoadjuvant Chemotherapy","volume":"272","author":"Parikh","year":"2014","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0125","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/mrm.24782","article-title":"DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings","volume":"71","author":"Li","year":"2014","journal-title":"Magn. Reson. Med."},{"issue":"8","key":"10.1016\/j.ejrad.2021.109931_b0130","first-page":"699","article-title":"Semiquantitative assessment of wash out parameter in dynamic contrast enhanced MRI for evaluating therapeutic effect of locally advanced breast cancer after neoadjuvant chemotherapy","volume":"47","author":"Shi","year":"2013","journal-title":"Chinese J. Radiol. (China)"},{"issue":"6","key":"10.1016\/j.ejrad.2021.109931_b0135","first-page":"463","article-title":"MRI in the evaluation of breast cancer patient response to neoadjuvant chemotherapy: predictive factors for breast conservative surgery","volume":"19","author":"Nadrljanski","year":"2013","journal-title":"Diagnostic Interventional Radiol."},{"issue":"2","key":"10.1016\/j.ejrad.2021.109931_b0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clbc.2011.11.002","article-title":"Dynamic breast magnetic resonance imaging: pretreatment prediction of tumor response to neoadjuvant chemotherapy","volume":"12","author":"Dongfeng","year":"2012","journal-title":"Clin. Breast cancer"},{"issue":"20","key":"10.1016\/j.ejrad.2021.109931_b0145","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1158\/1078-0432.CCR-07-4310","article-title":"Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer","volume":"14","author":"Ah-See","year":"2008","journal-title":"Clin. Cancer Res. Official J. Am. Association Cancer Res."},{"issue":"5","key":"10.1016\/j.ejrad.2021.109931_b0150","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2214\/AJR.07.3567","article-title":"Dynamic Contrast-Enhanced MRI for Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: Initial Results","volume":"191","author":"Loo","year":"2008","journal-title":"Am. J. Roentgenol."},{"issue":"12","key":"10.1016\/j.ejrad.2021.109931_b0155","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/nbm.2807","article-title":"Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS","volume":"25","author":"Shin","year":"2012","journal-title":"NMR Biomed."},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002420","article-title":"Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer","volume":"95","author":"Che","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.ejrad.2021.109931_b0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mri.2017.06.002","article-title":"Pre-operative assessment of residual disease in locally advanced breast cancer patients: A sequential study by quantitative diffusion weighted MRI as a function of therapy","volume":"42","author":"Agarwal","year":"2017","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2021.109931_b0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mri.2017.12.018","article-title":"Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer","volume":"48","author":"Kim","year":"2018","journal-title":"Magn. Reson. Imaging"},{"issue":"2","key":"10.1016\/j.ejrad.2021.109931_b0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.acra.2017.08.009","article-title":"Apparent Diffusion Coefficient Value to Evaluate Tumor Response After Neoadjuvant Chemotherapy in Patients with Breast Cancer","volume":"25","author":"Ram\u00edrez-Galv\u00e1n","year":"2018","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejrad.2021.109931_b0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fonc.2018.00319","article-title":"Can Multi-Parametric MR Based Approach Improve the Predictive Value of Pathological and Clinical Therapeutic Response in Breast Cancer Patients?","volume":"8","author":"Sharma","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2021.109931_b0185","doi-asserted-by":"crossref","unstructured":"N.P. Pereira, C. Curi, C. Os\u00f3rio, E.F. Marques, F.B. Makdissi, K. Pinker. Diffusion-Weighted Magnetic Resonance Imaging of Patients with Breast Cancer Following Neoadjuvant Chemotherapy Provides Early Prediction of Pathological Response - A Prospective Study2019;9(1):16372. http:\/\/dx.doi.org\/10.1038\/s41598-019-52785-3.","DOI":"10.1038\/s41598-019-52785-3"},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0190","first-page":"338","article-title":"Whole-lesion histogram analysis of apparent diffusion coefficient for the prediction of pathological complete response to neoadjuvant chemotherapy in different subtypes of breast cancer","volume":"54","author":"Wang","year":"2020","journal-title":"Chinese J. Radiol. (China)"},{"issue":"11","key":"10.1016\/j.ejrad.2021.109931_b0195","first-page":"2036","article-title":"Assessment of apparent diffusion coeffient in breast cancer response to neoadjuvant chemotherapy: Comparison of different measuring method","volume":"25","author":"Wu","year":"2009","journal-title":"Chinese J. Med. Imaging Technol."},{"issue":"12","key":"10.1016\/j.ejrad.2021.109931_b0200","first-page":"2480","article-title":"Correlation between apparent diffusion coefficient value and pathologic response of locally advanced breast cancer after neoadjuvant chemotherapy","volume":"27","author":"Shi","year":"2011","journal-title":"Chinese J. Med. Imaging Technol."},{"issue":"5","key":"10.1016\/j.ejrad.2021.109931_b0205","first-page":"731","article-title":"Predictive value of ADC for the effect of neoadjuvant chemotheraphy on breast cancer: A prospective exploration","volume":"29","author":"Zhang","year":"2013","journal-title":"Chinese J. Med. Imaging Technol."},{"issue":"6","key":"10.1016\/j.ejrad.2021.109931_b0210","first-page":"1336","article-title":"Evaluation of pathologic response of breast cancer to neoadjuvant chemotherapy with magnetic resonance diffusion weighted imaging","volume":"31","author":"Luo","year":"2014","journal-title":"J. Biomed. Eng."},{"key":"10.1016\/j.ejrad.2021.109931_b0215","doi-asserted-by":"crossref","unstructured":"Y.Y. An, S.H. Kim. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET\/CT2015;30(6):808-15. http:\/\/dx.doi.org\/10.3346\/jkms.2015.30.6.808.","DOI":"10.3346\/jkms.2015.30.6.808"},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0220","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejrad.2016.02.006","article-title":"Multi-parametric MRI in the early prediction of response to neo-adjuvant chemotherapy in breast cancer: Value of non-modelled parameters","volume":"85","author":"O'Flynn","year":"2016","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0225","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.ejrnm.2016.06.003","article-title":"Role of MRI diffusion as an adjunct to contrast enhanced MRI of the breast for the evaluation of breast cancer patients receiving neoadjuvent chemotherapy","volume":"47","author":"El Kassas","year":"2016","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"issue":"6","key":"10.1016\/j.ejrad.2021.109931_b0230","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1524-4741.2011.01160.x","article-title":"Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment","volume":"17","author":"Belli","year":"2011","journal-title":"Breast J."},{"issue":"4","key":"10.1016\/j.ejrad.2021.109931_b0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/RLI.0000000000000100","article-title":"Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer","volume":"50","author":"Li","year":"2015","journal-title":"Invest. Radiol."},{"issue":"2","key":"10.1016\/j.ejrad.2021.109931_b0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejrad.2013.10.023","article-title":"Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy","volume":"83","author":"Hahn","year":"2014","journal-title":"Eur. J. Radiol."},{"issue":"9","key":"10.1016\/j.ejrad.2021.109931_b0245","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ejrad.2014.05.002","article-title":"Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment","volume":"83","author":"Bufi","year":"2014","journal-title":"Eur. J. Radiol."},{"issue":"6","key":"10.1016\/j.ejrad.2021.109931_b0250","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s00330-010-2020-3","article-title":"Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging","volume":"21","author":"Fangberget","year":"2011","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.ejrad.2021.109931_b0255","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1148\/radiol.2542090405","article-title":"Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging\u2013comparison with contrast-enhanced MR imaging and pathologic findings","volume":"254","author":"Woodhams","year":"2010","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0260","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1148\/radiol.2461061298","article-title":"Meta-analysis of MR imaging in the diagnosis of breast lesions","volume":"246","author":"Peters","year":"2008","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JMI.5.1.011011","article-title":"Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis","volume":"5","author":"Virostko","year":"2018","journal-title":"J. Med. Imaging"},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0270","article-title":"Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: A meta-analysis","volume":"16","author":"Gao","year":"2018","journal-title":"World J. Surgical Oncol."},{"key":"10.1016\/j.ejrad.2021.109931_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00093","article-title":"The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis","volume":"10","author":"Cheng","year":"2020","journal-title":"Frontiers Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11604-007-0187-6","article-title":"Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer","volume":"26","author":"Matsuoka","year":"2008","journal-title":"Radiation Med."},{"issue":"1","key":"10.1016\/j.ejrad.2021.109931_b0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-012-2033-5","article-title":"Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?","volume":"135","author":"Wu","year":"2012","journal-title":"Breast Cancer Res. Treat."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X21004125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X21004125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:27:48Z","timestamp":1759994868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X21004125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":57,"alternative-id":["S0720048X21004125"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.109931","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2021.109931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109931"}}